Dnascript
Paris, FR · 2 known investors
DNA Script develops enzymatic DNA synthesis technology, offered through its SYNTAX platform, that lets labs produce high-quality ssDNA oligos in-house and overnight. It serves research and life sciences customers including CROs, core facilities, biotech and pharma companies, and government agencies.
BiotechDeep TechHardware
Investors · 2
Frequently asked questions
- What does Dnascript do?
- DNA Script develops enzymatic DNA synthesis technology, offered through its SYNTAX platform, that lets labs produce high-quality ssDNA oligos in-house and overnight. It serves research and life sciences customers including CROs, core facilities, biotech and pharma companies, and government agencies.
- Who are Dnascript's investors?
- Dnascript's investors include Kurma Partners, M Ventures.
- Where is Dnascript headquartered?
- Dnascript is headquartered in Paris, FR.